Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 14.36% is 51% below its 5-year average of 29.14%, near the low end of its 5-year range (14.36%–35.92%).
As of the fiscal period ended Wednesday, December 31, 2025. 29.10% below its 12-month average of 20.25%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
14.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
20.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
26.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
29.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
30.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
25.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
23.10%
CURRENT VS TTM AVG
-29.10%
CURRENT VS 3Y AVG
-46.46%
CURRENT VS 5Y AVG
-50.72%
CURRENT VS 10Y AVG
-52.40%
CURRENT VS 15Y AVG
-44.56%
CURRENT VS 20Y AVG
-37.84%
SECTOR MEDIAN · HEALTHCARE
8.78%
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
+63.55%
vs the sector median at left
NRC Health
Market Cap
$481.83M
Return on Invested Capital (ROIC)
14.36%
TTM Avg
20.25%
3Y Avg
26.82%
5Y Avg
29.14%
Market Cap
$406.47M
Return on Invested Capital (ROIC)
-14.80%
TTM Avg
-28.02%
3Y Avg
-25.91%
5Y Avg
-25.91%
Market Cap
$1.24B
Return on Invested Capital (ROIC)
-8.26%
TTM Avg
-20.40%
3Y Avg
-90.85%
5Y Avg
-61.23%
Market Cap
$2.33B
Return on Invested Capital (ROIC)
5.67%
TTM Avg
-6.15%
3Y Avg
-6.50%
5Y Avg
-3.41%
Market Cap
$3.09B
Return on Invested Capital (ROIC)
10.94%
TTM Avg
7.96%
3Y Avg
-0.14%
5Y Avg
-9.11%
Market Cap
$6.82B
Return on Invested Capital (ROIC)
6.02%
TTM Avg
9.35%
3Y Avg
-2.77%
5Y Avg
-9.72%
Market Cap
$7.25B
Return on Invested Capital (ROIC)
N/A
TTM Avg
-12.21%
3Y Avg
-19.73%
5Y Avg
-18.73%
Market Cap
$9.59B
Return on Invested Capital (ROIC)
2.04%
TTM Avg
2.21%
3Y Avg
2.35%
5Y Avg
2.39%
Market Cap
$9.76B
Return on Invested Capital (ROIC)
-10.90%
TTM Avg
-59.32%
3Y Avg
-58.49%
5Y Avg
-53.68%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRC Health (NRC) | $481.83M | 14.36% | 20.25% | 26.82% | 29.14% |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | -14.80% | -28.02% | -25.91% | -25.91% |
| Teladoc Health, Inc. (TDOC)vs › | $1.24B | -8.26% | -20.40% | -90.85% | -61.23% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.33B | 5.67% | -6.15% | -6.50% | -3.41% |
| TransMedics Group, Inc. (TMDX)vs › | $3.09B | 10.94% | 7.96% | -0.14% | -9.11% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.82B | 6.02% | 9.35% | -2.77% | -9.72% |
| Oscar Health, Inc. (OSCR)vs › | $7.25B | N/A | -12.21% | -19.73% | -18.73% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.59B | 2.04% | 2.21% | 2.35% | 2.39% |
| Tempus AI, Inc. (TEM)vs › | $9.76B | -10.90% | -59.32% | -58.49% | -53.68% |
| Insulet Corp. (PODD)vs › | $10.02B | 13.62% | 12.65% | 8.97% | 7.27% |
ROIC
14.4%
ROE
89.4%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 14.36% |
| 2024-12-31 | 26.15% |
| 2023-12-31 | 33.00% |
| 2022-12-31 | 33.77% |
| 2021-12-31 | 31.65% |
| 2020-12-31 | 35.92% |
| 2019-12-31 | 44.32% |
| 2018-12-31 | 47.13% |
| 2017-12-31 | 23.82% |
| 2016-12-31 | 22.22% |
| 2015-12-31 | 19.48% |
| 2014-12-31 | 17.57% |
| 2013-12-31 | 17.49% |
| 2012-12-31 | 19.95% |
| 2011-12-31 | 15.25% |
| 2010-12-31 | 12.38% |
| 2009-12-31 | 15.72% |
| 2008-12-31 | 13.76% |
| 2007-12-31 | 14.57% |
| 2006-12-31 | 12.23% |
| 2005-12-31 | 14.38% |
| 2004-12-31 | 10.99% |
| 2003-12-31 | 11.23% |
| 2002-12-31 | 11.82% |
| 2001-12-31 | 5.98% |
| 2000-12-31 | 8.72% |
| 1999-12-31 | 6.42% |
| 1998-12-31 | 10.76% |
| 1997-12-31 | 23.67% |
| 1996-12-31 | 90.79% |
